RIMIPLAGENE PARVEC
UNII 9MR3HPW3LF

Substance Identification & Data

This profile provides standardized clinical and technical data for Rimiplagene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9MR3HPW3LF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3062583-57-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
9MR3HPW3LF
CAS Registry Number
3062583-57-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RIMIPLAGENE PARVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
13985
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rimiplagene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RIMIPLAGENE PARVEC

Common Names & Synonyms

RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE RHESUS 10 (RAAVRH.10) VECTOR ENCODING HUMAN PLAKOPHILIN-2 (PKP2) ISOFORM A, PRECEDED BY A KOZAK SEQUENCE AND UNDER CONTROL OF A TRUNCATED CARDIAC-SPECIFIC CHICKEN TROPONIN T PROMOTER, A MUTATED WOODCHUCK HEPATITIS VIRUS POST-TRANSCRIPTIONAL REGULATORY ELEMENT (WPRE) AND A RABBIT .BETA.-GLOBIN POLYADENYLATION SIGNAL; FLANKED BY AAV2 INVERTED TERMINAL REPEATS (ITRS)
RIMIPLAGENE PARVEC [INN]

Technical Codes

LX-2020

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record